News

Pressure BioSciences to Discuss Recent Achievements and Upcoming Commercialization of its Enabling UST Platform at the Sequire Cannabis & Psychedelics Conference

Company Invites Investors, Analysts, and Advisors to Attend Its Virtual Presentation on Wednesday, April 20th at 10:30am EDTSOUTH EASTON, MA…

2 years ago

Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021

CHICAGO, IL / ACCESSWIRE / April 19, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with…

2 years ago

Sean Hӓgen of BlackHӓgen Design to Present at the 2022 the [PACK](TM)out Conference

DUNEDIN, FL / ACCESSWIRE / April 19, 2022 / Sean Hӓgen, BlӓckHagen Design Principal, Founder, and Director of Synthesis, will…

2 years ago

Altamira Reaches COVAMID Trial Enrollment Midpoint for Bentrio in Acute COVID-19

HAMILTON, BERMUDA / ACCESSWIRE / April 19, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that…

2 years ago

Avinger Announces Full Commercial Launch of Lightbox 3

REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and…

2 years ago

Aytu BioPharma Announces Fast Track Designation Granted to AR101 for the Treatment of Vascular Ehlers-Danlos Syndrome

ENGLEWOOD, CO / ACCESSWIRE / April 19, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and…

2 years ago

Petvivo Holdings, Inc. To Present at the Planet Microcap Showcase 2022 in Las Vegas

MINNEAPOLIS, MN / ACCESSWIRE / April 19, 2022 / PetVivo Holdings, Inc. (NASDAQ:PETV)(NASDAQ:PETVW) ("PetVivo") an emerging biomedical device company focused…

2 years ago

Marijuana Company of America Reports Year 2021 Financial Results

LOS ANGELES, CA / ACCESSWIRE / April 19, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), operates,…

2 years ago

Moderna Announces Clinical Update on Bivalent COVID-19 Booster Platform

Moderna's first bivalent booster vaccine candidate, mRNA-1273.211, demonstrated superior neutralizing titers compared to mRNA-1273 against all variants of concern, including…

2 years ago

NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of Opening its Inaugural Specialty Mental Health Clinic

Initiates Medical Adoption Program with Impetus Digital, a Leading Healthcare Platform for Virtual Medical EducationOAKVILLE, ON / ACCESSWIRE / April…

2 years ago